SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

01 Jun 2024 Evaluate
The sales moved up 26.10% to Rs. 373.32 millions for the March 2024 quarter as compared to Rs. 296.06 millions during the year-ago period.Net profit surges 88.07% to Rs. 125.93  millions  from Rs. 66.96 millions in the quarter ended March 2024.Operating Profit saw a handsome growth to 182.55 millions from 89.80 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 373.32 296.06 26.10 1258.95 913.58 37.80 1258.95 913.58 37.80
Other Income 13.24 3.40 289.41 30.67 7.17 327.75 30.67 7.17 327.75
PBIDT 182.55 89.80 103.29 448.77 241.60 85.75 448.77 241.60 85.75
Interest 1.46 0.77 89.61 5.98 1.80 232.22 5.98 1.80 232.22
PBDT 181.09 89.03 103.40 442.79 239.80 84.65 442.79 239.80 84.65
Depreciation 18.57 10.32 79.94 61.10 37.42 63.28 61.10 37.42 63.28
PBT 162.52 78.71 106.48 381.69 202.38 88.60 381.69 202.38 88.60
TAX 36.59 11.75 211.40 100.52 50.53 98.93 100.52 50.53 98.93
Deferred Tax -0.15 -2.33 -93.56 6.74 -2.84 -337.32 6.74 -2.84 -337.32
PAT 125.93 66.96 88.07 281.17 151.85 85.16 281.17 151.85 85.16
Equity 125.83 121.07 3.93 125.83 121.07 3.93 125.83 121.07 3.93
PBIDTM(%) 48.90 30.33 61.21 35.65 26.45 34.79 35.65 26.45 34.79

Shree Ganesh Remed. Share Price

668.70 -34.30 (-4.88%)
22-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.45
Dr. Reddys Lab 1291.05
Cipla 1415.30
Zydus Lifesciences 1084.35
Lupin 2339.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: